BIO SB Hepatocyte Specific Antigen / Hep-Par 1 (OCH1E5), MMab
For In Vitro Diagnostic Use
Description
Hepatocyte Specific Antigen (HSA or Hep Par 1) has been demonstrated consistently in the vast majority of Hepatocellular Carcinomas. Studies have shown the utility of HSA in the differential diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Hepatoblastomas. Hepatocyte Specific Antigen recognizes both benign and malignant liver derived tissues including such tumors as Hepatoblastoma, Hepatocellular Carcinoma, and Hepatic Adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating Hepatocellular Carcinomas with adenoid features from Adenocarcinomas, either primary in the liver or metastatic lesions to the liver. In recognizing Hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.
Synonymes
benign, malignant, liver cells, tumors, hepatoblastoma, hepatocellular carcinoma, hepatic adenoma, hsa, hep par 1, hep-par-1, anti-hep par 1, Hepatocyte Specific Antigen, anti-Hepatocyte Specific Antigen, anti Hepatocyte Specific Antigen
Caractéristiques
- Type
- Mouse Monoclonal
- Clone
- OCH1E5
- Isotype
- IgG1/K
- Réactivité
- Paraffin, Frozen
- Localisation
- Cytoplasmic
- Contrôle
- Liver, Liver Carcinoma
- Usage prévu
- For In Vitro Diagnostic Use
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.